NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
CAPLIN POINT LABORATORIES LTD. (BSE: 524742)
524742 Technical Analysis
5
As on 24th Dec 2024 524742 SHARE Price closed @ 2398.45 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1266.65 & Strong Buy for SHORT-TERM with Stoploss of 1374.19 we also expect STOCK to react on Following IMPORTANT LEVELS. |
524742SHARE Price
Open | 2443.95 | Change | Price | % |
High | 2443.95 | 1 Day | -26.10 | -1.08 |
Low | 2373.50 | 1 Week | 939.00 | 64.34 |
Close | 2398.45 | 1 Month | 939.00 | 64.34 |
Volume | 9785 | 1 Year | 993.45 | 70.71 |
52 Week High 2443.95 | 52 Week Low 1221.00 |
BSE INDIA Most Active Stocks
532822 | 7.47 | -0.13% |
532411 | 0.41 | 0.00% |
517001 | 0.09 | 12.50% |
511700 | 1.01 | -0.98% |
512149 | 0.88 | 0.00% |
511389 | 7.25 | -2.42% |
534690 | 7.65 | 4.79% |
532775 | 2.04 | -0.97% |
531328 | 1.05 | 0.96% |
532648 | 19.80 | -0.60% |
BSE INDIA Top Gainers Stocks
BSE INDIA Top Losers Stocks
524742 Daily Charts |
524742 Intraday Charts |
Whats New @ Bazaartrend |
524742 Free Analysis |
|
524742 Important Levels Intraday
RESISTANCE | 2534.21 |
RESISTANCE | 2490.67 |
RESISTANCE | 2463.76 |
RESISTANCE | 2436.85 |
SUPPORT | 2360.05 |
SUPPORT | 2333.14 |
SUPPORT | 2306.23 |
SUPPORT | 2262.69 |
524742 Target May 2025
4th UP Target | 0 |
3rd UP Target | 0 |
2nd UP Target | 0 |
1st UP Target | 0 |
1st DOWN Target | 0 |
2nd DOWN Target | 0 |
3rd DOWN Target | 0 |
4th DOWN Target | 0 |
524742 Weekly Target
4th UP Target | 0.00 |
3rd UP Target | 0.00 |
2nd UP Target | 0.00 |
1st UP Target | 0.00 |
1st DOWN Target | 0.00 |
2nd DOWN Target | 0.00 |
3rd DOWN Target | 0.00 |
4th DOWN Target | 0.00 |
524742 Target2025
4th UP Target | 3007.16 |
3rd UP Target | 2477.69 |
2nd UP Target | 2150.41 |
1st UP Target | 1823.13 |
1st DOWN Target | 889.27 |
2nd DOWN Target | 561.99 |
3rd DOWN Target | 234.71 |
4th DOWN Target | -294.76 |
CAPLIN POINT LABORATORIES LTD. ( BSE INDIA Symbol : 524742 )
Sector : Other And Other Stocks in Same Sector
Sector : Other And Other Stocks in Same Sector
524742 Other Details
Segment | EQ | |
Market Capital | 40041512960.00 | |
Sector | Other | |
Industry | Other | |
Offical website | > echo $website ; ?> |
524742 Address
![]() |
524742 Latest News
524742 Business Profile
Caplin Point Laboratories Limited develops, manufactures, markets, and exports generic pharmaceutical formulations and branded generic products in India and internationally. It provides tablets, capsules, vials, ophthalmic products, liquid orals, soft gel capsules, ointments, creams and gels, powder for injections, suppositories and ovules, dermo cosmetics, surgicals and disposables, pre-mix bag formulations, inhalers and sprays, IV infusion products, dry syrups, topicals, and other products, as well as liquid, lyophilized, and pre-filled injection syringes. The company also operates QueTenX, an e-commerce website. Caplin Point Laboratories Limited was founded in 1990 and is based in Chennai, India. Address: Ashvich Tower, Chennai, India, 600096
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service